Business Today

The Promise Of Precision Medicine

"Large scale genome sequencing and correlating the DNA signatures with specific disease or drug sensitivity will allow clinicians to specify personalised treatment," says Rakesh K Mishra, Director, Centre for Cellular and Molecular Biology.

Our body is a complex machine with hundreds of parts, and its maintenance is critically linked to the information stored in our DNA sequences. It not only determines our body's response to medicines but also how our body reacts to the environment around us. Understanding the genetic framework is, therefore, essential if we have to treat any medical condition.

Getting a complete genome sequence done at an affordable cost and within a very short span (say, within a few days) is the way ahead, and we are getting there. Empowering clinicians with these details will open the doors to

You’re reading a preview, subscribe to read more.

More from Business Today

Business Today5 min read
Recipe For Success
IN JULY 2022, just a year after debuting in the stock exchange at ₹115, Zomato’s share price nosedived to below ₹50. Its future seemed uncertain. A non-profitable start-up hitting the stock market was a bold move—and, to some, even reckless. Investor
Business Today7 min read
Win Some, Lose Some
ROBUST INFLOWS FROM domestic investors supported the Indian equity market during this year’s study period (October 2023 to September 2024) of the BT500 list of India’s most valuable companies. Overall, the average market capitalisation (m-cap) of the
Business Today5 min read
Home Run
IF THE DECADE before the Covid-19 pandemic for the real estate sector was defined by stagnant growth, poor execution of projects, and occasional disruptions due to fraudulent practices by developers, the years that have followed since have been marke

Related Books & Audiobooks